AstriVax Therapeutics Further Strengthens Team with the Appointment of Dieter Weinand as New Chair of the Board of Directors

US-based Dieter Weinand is the…

AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using LaunchiT technology

Third asset to advance into…

AstriVax, an innovative vaccine platform company, establishes scientific advisory board with world renowned leaders in vaccine development

• Emmanuel Hanon, PhD, will…

KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform

KU Leuven spin-off AstriVax raises…